urief silodosin capsule 4mg 14capsules per bottle per box

Description

Indication & Scope

Urief® (Silodosin Capsules) is a prescription selective α1A-adrenoceptor antagonist indicated for the treatment of the signs and symptoms of benign prostatic hyperplasia (BPH), including urinary frequency, urgency, nocturia, weak urinary stream, hesitancy, and incomplete bladder emptying.

Mechanism: Silodosin selectively blocks α1A-adrenergic receptors in the prostate, bladder neck, and urethra, relaxing smooth muscle and improving urinary flow while minimizing effects on blood pressure.
Drug Class: Selective α1A-Adrenoceptor Antagonist.
Clinical Use: Symptomatic treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia.

Specification

Generic Name	Silodosin Capsules
Brand Name	Urief®
Ingredient	Silodosin
Dosage Form	Capsule
Package	4 mg × 14 capsules/bottle
Conditions Treated	Benign prostatic hyperplasia (BPH), urinary frequency, urgency, nocturia, weak urinary stream, incomplete bladder emptying
Taboos	Hypersensitivity to silodosin; severe renal impairment; concomitant use with strong CYP3A4 inhibitors
Place of origin	China
Prescription type	Prescription Only (Rx)
Storage Conditions	Store in a dry place at 10–30°C. Protect from moisture and light.
Manufacturer	DAICHI SANKYO PHARMACEUTICAL (SHANGHAI) CO., LTD.
Registration Authority	National Medical Products Administration (NMPA), China
Approval Number	H20110100
Approval Date	August 11, 2021
Shelf Life	36 months

How to use ?

Recommended Dose: Take 4 mg twice daily, preferably after breakfast and dinner, swallowed whole with water.

Time: Do not crush, chew, or open the capsule. Take at approximately the same time each day.

Instructions for use: Mild renal impairment: No dose adjustment required. Moderate renal impairment: Dose reduction may be considered. Severe renal impairment (CrCl <30 mL/min): Contraindicated.

Interaction: Avoid concomitant use with strong CYP3A4 inhibitors (such as ketoconazole, itraconazole, clarithromycin, and ritonavir). Use caution when combined with antihypertensive agents or PDE5 inhibitors because of the potential for hypotension.

Side effects: Common adverse reactions include retrograde ejaculation, dizziness, orthostatic hypotension, nasal congestion, diarrhea, and reduced ejaculatory volume. Seek immediate medical attention if severe allergic reactions, syncope, or significant hypotension occur.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References

2.NMPA

3.FDA

4.EMA

FAQ

What is Urief® used for?

It is used to relieve urinary symptoms caused by benign prostatic hyperplasia (BPH), including urinary frequency, urgency, nocturia, weak stream, and difficulty urinating.

How should I take Urief®?

Take one 4 mg capsule twice daily after meals, swallowing the capsule whole with water.

Can this medicine affect ejaculation?

Yes. Retrograde ejaculation or decreased semen volume is one of the most common effects. These changes are generally reversible after discontinuation.

Can I take Urief® with blood pressure medicines?

Use caution. Combining Urief® with antihypertensive drugs may increase the risk of low blood pressure and dizziness. Consult your healthcare provider before taking them together.